ASSOCIATION OF miRNA AND TARGET GENES OF PARKINSON’S DISEASE


  • А. Aralbayeva Asfendiyarov Kazakh National Medical University, Kazakhstan
  • S.U. Kamenova Asfendiyarov Kazakh National Medical University, Kazakhstan
  • А.Т. Ivashchenko Al-Farabi Kazakh National University, Kazakhstan
  • A.N. Akimniyazova Al-Farabi Kazakh National University, Kazakhstan
Keywords: biomarker, Parkinson’s diseases, miRNA, binding sites cluster, target gene

Abstract

ASSOCIATION OF miRNA AND TARGET GENES OF PARKINSON’S DISEASE

References

1. Li J. et al. Identification of critical genes and miRNAs associated with the development of Parkinson’s disease. J MolNeurosci. 2018. doi: 10.1007/s12031-018-1129-8.

2. Burgos K. et al. Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer’s and Parkinson’s diseases correlate with disease status and features of pathology. PLoS One. 2014;9(5):e94839. doi: 10.1371/ journal.pone.0094839. eCollection 2014.

3. Rostamian D.M. et al.Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson’s disease. Gene. 2018;662:54-65.doi: 10.1016/j.gene.2018.04.010.

4. Londin E., et al. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. PNAS. 2015;112(10):1106-1115. doi: 10.1073/pnas.

5. Witoelar A. et al. Genome-wide pleiotropy between Parkinson disease and autoimmune diseases.JAMA Neurol. 2017; 74(7): 780–792. Jul 10. doi: 10.1001/jamaneurol.2017.0469.

6. Golpich M. et al.Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson’s disease. Res. 2015;97:16-26. doi: 10.1016/j.phrs.2015.03.010.

7. Quadri M. et al. LRP10 genetic variants in familial Parkinson’s disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study. Lancet Neurol. 2018;17(7):597-608. doi: 10.1016/S1474-4422(18)30179-0.

8. Niyazova R. et al. miR-1322 binding sites in paralogous and orthologous genes. BioMed Research Int. 2015, 1-7, http:// dx.doi.org/10.1155/2015/962637.

9. Atambayeva Sh, Niyazova R, Ivashchenko A, Pyrkova A, Pinsky I, Akimniyazova A, Labeit S. The binding sites of miR- 619-5p in the mRNAs of human and orthologous genes.BMC Genomics.2017; 18:428.doi:10.1186/s12864-017-3811-6

10. Freeze B. et al. Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease. NeuroimageClin. 2018;18:456-466. doi: 10.1016/j.nicl.2018.01.009. eCollection 2018.

11. Witoelar A. et al. Genome-wide pleiotropy between Parkinson disease and autoimmune diseases. JAMA Neurol.2017;74(7):780-792. doi: 10.1001/jamaneurol.2017.0469.

12. Recabarren D. et al. Gene networks in neurodegenerative disorders. Life Sci. 2017;183:83-97.doi: 10.1016/j. lfs.2017.06.009.
Published
2018-11-15
How to Cite
AralbayevaА., Kamenova, S., IvashchenkoА., & Akimniyazova, A. (2018). ASSOCIATION OF miRNA AND TARGET GENES OF PARKINSON’S DISEASE. Biological Markers in Fundamental and Clinical Medicine (scientific Journal), 2(2), 9-11. https://doi.org/10.29256/v.02.02.2018.escbm04
Section
Selected abstracts